Inventor
TERU HIDESHIMA
Inventor
US
Overview
Patents· 5 as inventor
Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.
A61Kprimary
A61KPreparations for medical, dental or toiletry purposes25%
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations25%
C07DHeterocyclic compounds25%
C07KPeptides19%
C07CAcyclic or carbocyclic compounds6%
PatentTitleYear
12,053,468Pharmaceutical combinations comprising a histone deacetylase inhibitor and a CD38 inhibitor and methods of use thereof202411,497,746Pharmaceutical combinations comprising a histone deacetylase inhibitor and a programmed death-ligand 1 (PD-L1) inhibitor and methods of use thereof2022RE049240Inhibitors of histone deacetylase202211,447,467Compounds for the degradation of STK4 and treatment of hematologic malignancies202211,337,975Pharmaceutical combinations comprising a histone deacetylase inhibitor and a CD38 inhibitor and methods of use thereof2022Career & activity timeline
Assembled from patent assignee/location history and declaration credentials.
2022–2024Patents assigned to ACETYLON PHARMACEUTICALS INC (3)· patent assignee history
2022Patents assigned to DANA FARBER CANCER INST INC (2)· patent assignee history
2022Patents assigned to MASSACHUSETTS GEN HOSPITAL (1)· patent assignee history
2022–2024Based in US· patent location history
Inventor activity
Assignee and location history derived from the patent record.
Assignees
| Assignee | Patents | Span |
|---|---|---|
| ACETYLON PHARMACEUTICALS INC | 3 | 2022–2024 |
| DANA FARBER CANCER INST INC | 2 | 2022 |
| MASSACHUSETTS GEN HOSPITAL | 1 | 2022 |
Locations
| Location | Patents | Span |
|---|---|---|
| US | 5 | 2022–2024 |